News
CERS
2.275
+5.81%
0.125
Weekly Report: what happened at CERS last week (0708-0712)?
Weekly Report · 9h ago
Weekly Report: what happened at CERS last week (0701-0705)?
Weekly Report · 07/08 11:20
Dean Gregory Joins Cerus Board with Compensation Package
TipRanks · 07/02 20:33
CERUS CORPORATION ANNOUNCES APPOINTMENT OF DEAN GREGORY TO BOARD OF DIRECTORS
Reuters · 07/02 20:00
Weekly Report: what happened at CERS last week (0624-0628)?
Weekly Report · 07/01 11:21
Weekly Report: what happened at CERS last week (0617-0621)?
Weekly Report · 06/24 11:28
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation announces a lunch symposium and selection of abstracts at the 38th International Congress of the International Society of Blood Transfusion. The conference is taking place in Barcelona, Spain, from June 23 through June 27. Cerus will be in the exhibition area at the congress.
Barchart · 06/21 07:30
Weekly Report: what happened at CERS last week (0610-0614)?
Weekly Report · 06/17 11:19
Cerus Corporation Celebrates World Blood Donor Day 2024
In 2005, the World Health Assembly designated June 14 as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. Cerus Corporation will celebrate World Blooddonor Day 2024. The focus of the day is on all blood donors. More than 118.5 million blood donations are collected annually.
Barchart · 06/14 07:30
Cerus Stockholders Endorse New Plans and Board Members
TipRanks · 06/11 21:01
Weekly Report: what happened at CERS last week (0603-0607)?
Weekly Report · 06/10 11:21
Cerus: Statement of changes in beneficial ownership of securities
Press release · 06/07 00:03
Weekly Report: what happened at CERS last week (0527-0531)?
Weekly Report · 06/03 11:24
Weekly Report: what happened at CERS last week (0520-0524)?
Weekly Report · 05/27 11:29
Weekly Report: what happened at CERS last week (0513-0517)?
Weekly Report · 05/20 11:22
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Dow Jones index closed lower by over 80 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Earth Science Tech, Inc. And Zomedica Corp.
Benzinga · 05/14 13:01
Weekly Report: what happened at CERS last week (0506-0510)?
Weekly Report · 05/13 11:35
ESS Tech And 2 Other Stocks Under $5 Insiders Are Buying
Insider transactions for penny stocks indicate confidence or concern around the company's prospects. ESS Tech, Inc. Director Harry Quarls bought a total of 42,690 shares at an average price of $0.84. Sabre Corporation CEO Kurt Ekert acquired 65,000 shares.
Benzinga · 05/10 11:21
Weekly Report: what happened at CERS last week (0429-0503)?
Weekly Report · 05/06 11:43
Cerus’s Strong Q1 Growth and Promising INTERCEPT Technology Drive Buy Rating
TD Cowen analyst Josh Jennings has maintained their bullish stance on CERS stock, giving a Buy rating on May 3. Cerus has a strong start to the year with a 24% growth in product revenue for the first quarter. The company is nearing complete adoption of their INTERCEPT technology in Canada.
TipRanks · 05/05 10:45
More
Webull provides a variety of real-time CERS stock news. You can receive the latest news about Cerus through multiple platforms. This information may help you make smarter investment decisions.
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.